{
 "awd_id": "9109179",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Continuing Grant",
 "awd_titl_txt": "Membrane-Based Process for the Synthesis of Chiral          Pyrethroids",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Charles R. Hauer",
 "awd_eff_date": "1992-06-01",
 "awd_exp_date": "1995-05-31",
 "tot_intn_awd_amt": 236272.0,
 "awd_amount": 236272.0,
 "awd_min_amd_letter_date": "1992-05-29",
 "awd_max_amd_letter_date": "1994-12-12",
 "awd_abstract_narration": "Many pesticides are chiral--that is, their chemical structures                  exist as a pair of \"hand\" enantiomers.  Generally, only one of                  the pair of enantiomers exhibits the desired biological activity.               Despite mounting evidence that critical pesticides should be                    developed and marketed as single enantiomers, more than 90% of                  the synthetic chiral pesticides are marketed as racemic mixtures,               which contain both enantiomers.  The principal reason is because                of the high cost and technical difficulty of preparing the                      enantiomerically pure chiral intermediates needed to prepare the                chiral pesticide.                                                                                                                                               The goal of this program is to develop a simple, cost-                          effective process to prepare enantiomerically pure (s)-m-                       phenoxybenzaldehyde cyanohydrin, an important chiral intermediate               used in the synthesis of pyrethroid insecticides--a commercially                important class of highly effective insecticides.  In Phase I, we               demonstrated the technical and economic feasibility of our                      approach, which is based on dual-membranes enzyme-reactor                       process.  In this Phase II program, we plan to characterize and                 optimize the process and, through construction and operation of a               bench-scale unit, generate the data necessary to commercialize                  the process with our probable Phase III sponsor, a major                        manufacturer of m-phenoxybenzaldehyde cyanohydrin.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Dwayne",
   "pi_last_name": "Friesen",
   "pi_mid_init": "T",
   "pi_sufx_name": "",
   "pi_full_name": "Dwayne T Friesen",
   "pi_email_addr": "bendresearch@bendres.com",
   "nsf_id": "000462729",
   "pi_start_date": "1994-12-12",
   "pi_end_date": null
  },
  {
   "pi_role": "Former Principal Investigator",
   "pi_first_name": "Paul",
   "pi_last_name": "van Eikeren",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "Paul van Eikeren",
   "pi_email_addr": "paul.van.eikeren@intellichem.com",
   "nsf_id": "000302473",
   "pi_start_date": "1993-12-29",
   "pi_end_date": "1994-12-12"
  }
 ],
 "inst": {
  "inst_name": "Bend Research Inc",
  "inst_street_address": "64550 Research Road",
  "inst_street_address_2": "",
  "inst_city_name": "Bend",
  "inst_state_code": "OR",
  "inst_state_name": "Oregon",
  "inst_phone_num": "5413824100",
  "inst_zip_code": "977018599",
  "inst_country_name": "United States",
  "cong_dist_code": null,
  "st_cong_dist_code": "OR",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "Bend Research Inc",
  "perf_str_addr": "64550 Research Road",
  "perf_city_name": "Bend",
  "perf_st_code": "OR",
  "perf_st_name": "Oregon",
  "perf_zip_code": "977018599",
  "perf_ctry_code": "US",
  "perf_cong_dist": null,
  "perf_st_cong_dist": "OR",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537300",
   "pgm_ele_name": "SBIR Phase II"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "0000",
   "pgm_ref_txt": "UNASSIGNED"
  },
  {
   "pgm_ref_code": "1417",
   "pgm_ref_txt": "CHEMICAL & BIOLOGICAL SEPAR"
  },
  {
   "pgm_ref_code": "OTHR",
   "pgm_ref_txt": "OTHER RESEARCH OR EDUCATION"
  }
 ],
 "app_fund": [
  {
   "app_code": "",
   "app_name": "",
   "app_symb_id": "",
   "fund_code": "",
   "fund_name": "",
   "fund_symb_id": ""
  },
  {
   "app_code": "0193",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0193",
   "fund_name": "",
   "fund_symb_id": ""
  },
  {
   "app_code": "0194",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0194",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 1992,
   "fund_oblg_amt": 134816.0
  },
  {
   "fund_oblg_fiscal_yr": 1994,
   "fund_oblg_amt": 101456.0
  }
 ],
 "por": null
}